Patents
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
02/2011
02/16/2011CN101220037B 10-substitution homocamptothecin compounds and uses
02/15/2011US7888505 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one carboxylic acids, their esters, and methods of synthesis thereof
02/15/2011US7888369 Oxazoloisoquinoline derivatives as thrombin receptor antagonists
02/15/2011US7888368 Treatment of drug-resistant tumors
02/15/2011US7888359 Cyclohexyl or piperidinyl carboxamide antibiotic derivatives
02/15/2011US7888285 2,4,6-phenyl substituted cyclic ketoenols
02/15/2011CA2461572C Polycyclic compounds having anti-tumor activity
02/15/2011CA2444895C Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors
02/15/2011CA2380272C Stable near-infrared (nir) marker dyes based on benzopyrylium-polymethines
02/10/2011WO2011017634A2 Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
02/10/2011WO2011016528A1 Aminopyrazole derivative
02/10/2011US20110034547 Chondropsin-class antitumor v-atpase inhibitor compounds, compositions and methods of use thereof
02/10/2011US20110034500 Spiroheterocyclic compounds and their uses as therapeutic agents
02/10/2011US20110034458 Pyridine methylene azolidinones and use thereof phosphoinositide inhibitors
02/10/2011US20110034434 Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
02/10/2011US20110033457 Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases
02/10/2011CA2770195A1 Aminopyrazole derivative
02/10/2011CA2769795A1 Enzymatic transamination of cyclopamine analogs
02/09/2011EP2281817A1 Substituted carbinol compound having cyclic linker
02/09/2011EP2280953A1 New substituted indolin-2-one derivatives and their use as p38 mitogen-activated kinase inhibitors
02/09/2011EP2280943A1 New substituted spiroýcycloalkyl-1,3'-indol¨-2'(1'h)-one derivatives and their use as p38 mitogen-activated kinase inhibitors.
02/09/2011EP2280940A1 Novel n-(2-amino-phenyl)-acrylamides
02/09/2011CN101970445A Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors
02/09/2011CN101970444A Organic compounds
02/09/2011CN101970428A Carboxamide compounds and their use as calpain inhibitors
02/09/2011CN101967150A Spiroheterocyclic compounds and their uses as therapeutic agents
02/09/2011CN101967146A Ep4 receptor inhibitors to treat rheumatoid arthritis
02/08/2011US7884124 Fluoro-substituted inhibitors of D-amino acid oxidase
02/08/2011US7884099 such as (R)-5'-[3-{1-(4-{1-[1-(3-Carboxy-1-cyclopropyl-7-fluoro-9-methyl-4-oxo-4H-quinolizine-8-yl)-pyrrolidin-3-yl-cyclopropyl]-methylamino}-piperidin-1-yl]-3'-hydroxy-benzoxazinorifamycin, useful as bactericides for the treatment of bacterial infections
02/08/2011CA2471755C Process for preparing scopine esters
02/08/2011CA2446924C 2-iminopyrrolidine derivatives
02/08/2011CA2439117C Polymorph forms of n-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2-oxopyrrolidin-1-yl)acetamide
02/03/2011WO2011014535A1 COMPOUNDS FOR THE REDUCTION OF β-AMYLOID PRODUCTION
02/03/2011WO2011014039A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
02/03/2011WO2011013752A1 Pharmaceutical composition containing fused hetero-ring derivative
02/03/2011WO2011012654A1 Hydroxyasenapine compounds, derivatives thereof and pharmaceutical compositions comprising same
02/03/2011WO2011011872A1 Novel spiro compounds useful as inhibitors of stearoyl-coenzyme a delta-9 desaturase
02/03/2011WO2010124042A3 Modulators of 5-ht receptors and methods of use thereof
02/03/2011US20110028508 Novel process for the preparation of scopine esters
02/03/2011US20110028507 Pyridine derivatives and methods of use thereof
02/03/2011US20110028465 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
02/03/2011US20110028464 Inhibitors of human immunodeficiency virus replication
02/03/2011US20110028390 Pyrazolospiroketone Acetyl-CoA Carboxylase Inhibitors
02/03/2011US20110027800 Derivatives of 1,2-dihydro-7-hydroxyquinolines Containing Fused Rings
02/03/2011CA2766515A1 Compounds for the reduction of .beta.-amyloid production
02/02/2011EP2280013A1 Production method for camptothecin derivative
02/02/2011EP2279187A1 Spirocyclic derivatives as histone deacetylase inhibitors
02/02/2011EP2278973A1 Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitors
02/02/2011CN101965382A Synthetic resin composition, and automotive interior/exterior material comprising the same
02/02/2011CN101965351A Benzofuropyrimidinones
02/02/2011CN101962384A Chromene compounds, a process for their preparation and pharmaceutical compositions containing them
02/02/2011CN101440073B Aromatic chlorethazine piperazine quaternary ammonium salt derivatives, and preparation and use thereof
02/01/2011US7880018 Epoxy compound and production process of same
02/01/2011CA2609634C Tetracyclic azapyrazinoindolines as 5-ht2 ligands
02/01/2011CA2494091C Substituted furo [2,3-b| pyridine derivatives
02/01/2011CA2481560C Multiple acting anti-angiogenic and cytotoxic compounds and methods for using the same
01/2011
01/27/2011WO2011010744A1 Chromene compound
01/27/2011WO2011010610A1 Catalyst precursor, method for producing the same, method for using the same, and reactor that uses the same
01/27/2011WO2011010014A1 Chromene derivatives, method for preparing same, and pharmaceutical compositions containing same
01/27/2011WO2011009897A1 Fused aminodihydropyrimidone derivatives
01/27/2011US20110021777 Process improvement
01/27/2011US20110021744 Process for preparing purified drug conjugates
01/27/2011US20110021594 Agents Useful for Reducing Amyloid Precursor Protein and Treating Dementia and Methods of Use Thereof
01/27/2011US20110021550 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation
01/27/2011US20110021549 Substituted benzofused derivatives and their use as vanilloid receptor ligands
01/27/2011US20110021543 Heterocyclic compounds and their use as pesticides
01/27/2011US20110021515 Dihyrofuropyrmindine compounds
01/27/2011US20110021493 Substituted tricyclic compounds and methods of use thereof
01/27/2011US20110021490 Chromene compounds, a process for their preparationand pharmaceutical compositions containing them
01/27/2011US20110020931 Proliferation promoting agent for neural stem cells
01/27/2011US20110020277 Dioxolane and Dioxolanone Fused Indolobenzadiazepine HCV NS5B Inhibitors
01/27/2011CA2768881A1 Fused aminodihydropyrimidone derivatives
01/26/2011EP2277882A1 Pipéridinic compounds, process for their préparation and pharmaceutical compositions containing them
01/26/2011EP2277873A1 Intermediate compound for the preparation of halichondrin analogs
01/26/2011EP2276766A1 Tricyclic antibiotics
01/26/2011EP2276765A1 Salinosporamide derivatives as proteasome inhibitors
01/26/2011CN101955486A Method for extracting tetrandrine
01/26/2011CN101955485A Preparation method of chelidonine
01/26/2011CN101250187B Fatty amido substituted methylindole quinoline derivatives as well as preparation method and use thereof as anti-tumour drugs
01/25/2011US7875729 Trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]oxepino [4,5-c]pyrrole; good isomeric purity; cyclization
01/25/2011US7875626 Therapeutic agents
01/25/2011US7875611 Ion channel modulating compounds and uses thereof
01/25/2011US7875602 Camptothecin derivatives as chemoradiosensitizing agents
01/25/2011CA2434299C Tricyclic androgen receptor modulator compounds and methods
01/25/2011CA2410233C Compounds for treating impaired fundic relaxation
01/25/2011CA2404125C Sulphonamido-substituted bridged bicycloalkyl derivatives
01/25/2011CA2339834C Water soluble prodrugs of hindered alcohols or phenols
01/21/2011CA2709341A1 New chromene derivatives, their preparation process and the pharmaceutical compositions containing these derivatives
01/20/2011WO2011008709A1 Apoptosis signal-regulating kinase inhibitors
01/20/2011WO2011006567A1 Aminopyridine derivatives for treating tumors and inflammatory diseases
01/20/2011WO2010102758A3 Halogenalkylmethylenoxy-phenyl-substituted ketoenols
01/20/2011US20110015248 Substituted heterocycles
01/20/2011US20110015219 (+)-Morphinans as Antagonists of Toll-Like Receptor 9 and Therapeutic Uses Thereof
01/20/2011US20110015198 Diarylmethylamide derivative having melanin-concentrating hormone receptor antagonism
01/20/2011US20110015175 Bicyclic Compounds for the Reduction of Beta-Amyloid Production
01/20/2011US20110015147 Anti-viral pyrimidine nucleoside analogues
01/20/2011CA2768169A1 Aminopyridine derivatives for the treatment of tumors and inflammatory diseases
01/20/2011CA2767894A1 Apoptosis signal-regulating kinase inhibitors
01/19/2011EP1534255B1 Processes for preparing 1,3-dioxolane nucleosides
01/19/2011CN1989117B Substituted benzothiazoles
1 ... 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 ... 298